ConductScience.org, home

Paper8980409

Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.

Kerr DJ and 12 others. Br J Cancer, 1996. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution. Papers, record 8980409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8980409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.
PubMed
Journal
Br J Cancer
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2019-05-15
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kerr DJD J
2Young AMA M
3Neoptolemos JPJ P
4Sherman MM
5Van-Geene PP
6Stanley AA
7Ferry DD
8Dobbie JWJ W
9Vincke BB
10Gilbert JJ
11el Eini DD
12Dombros NN
13Fountzilas GG

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimetabolites, AntineoplasticMajor topic
Drug Delivery SystemsMajor topic
FluorouracilMajor topic
Peritoneal NeoplasmsMajor topic
Adult
Aged
Drug Carriers
Female
Follow-Up Studies
Humans
Infusions, Parenteral
Male
Middle Aged
Peritoneal Dialysis

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05913674Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)Background

Source ClinicalTrials.gov

Download CSV of trials

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17438049Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy.Cancer Res1980https://conductscience.org/library/papers/7438049PubMed
27214359Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.Cancer Res1981https://conductscience.org/library/papers/7214359PubMed
37239541Penetration of substances into tumor tissue--a methodological study on cellular spheroids.In Vitro1981https://conductscience.org/library/papers/7239541PubMed
42926468A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.J Clin Oncol1989https://conductscience.org/library/papers/2926468PubMed
57917936Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma.Br J Cancer1994https://conductscience.org/library/papers/7917936PubMed
62688796Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy.Br J Surg1989https://conductscience.org/library/papers/2688796PubMed
72043717The analysis of 5-fluorouracil in human plasma by gas chromatography-negative ion chemical ionization mass spectrometry (GC-NICIMS) with stable isotope dilution.J Pharm Biomed Anal1991https://conductscience.org/library/papers/2043717PubMed
81551172Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1551172PubMed
98137338Pharmacokinetic principles of locoregional chemotherapy.Cancer Surv1993https://conductscience.org/library/papers/8137338PubMed
102293556
Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.
Cancer Res1990https://conductscience.org/library/papers/2293556PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
22415741Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis.Int J Clin Oncol2013https://conductscience.org/library/papers/22415741PubMed
18407591Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats.World J Gastroenterol2008https://conductscience.org/library/papers/18407591PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8980409

GET https://conductscience.org/api/papers/v1/8980409/authors